Literature DB >> 20971929

Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site.

Cuiyan Tan1, Mehak K Aziz, Jenna D Lovaas, Barbara P Vistica, Guangpu Shi, Eric F Wawrousek, Igal Gery.   

Abstract

Recently reported lines of Th9 cells, producing IL-9 and IL-10, were generated by polarization with IL-4 and TGF-β and activation with Abs against CD3 and CD28. In this paper, we analyzed features of Th9 lines similarly polarized but activated by the "natural mode" (i.e., exposure of CD4 cells to their target Ag, hen egg lysozyme [HEL] and APCs). Main observations are the following: 1) both IL-9 and IL-10 were expressed by the line cells, but with strikingly different kinetics, with IL-9 being produced rapidly, reaching a peak on day 3 in culture and declining sharply thereafter, whereas IL-10 production increased gradually, resembling IL-4 and IL-17 production by their corresponding lineage cells; 2) reactivation of Th9, following expansion, triggered faster and higher production of both IL-9 and IL-10; 3) incubating Th9 cells in polarizing media specific for other phenotypes stimulated moderate levels of phenotype switching to Th1 or Th17 but a massive switching to Th2; 4) Th9 cells induced moderate inflammation in HEL-expressing recipient eyes but only when producing high levels of IL-9; and 5) IL-9-producing donor cells were detected in the blood of Th9 recipients but not in their inflamed eyes, suggesting that similar to findings in culture, exposure to HEL in these eyes arrested the IL-9 production in Th9 cells. Collectively, these data provide new information concerning Th9 cells and reveal their uniqueness, in particular with regard to the unusual production kinetics of IL-9 and the short retention of these cells in affected target tissues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971929      PMCID: PMC2988091          DOI: 10.4049/jimmunol.1001676

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  How diverse--CD4 effector T cells and their functions.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  J Mol Cell Biol       Date:  2009-05-28       Impact factor: 6.216

2.  IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma.

Authors:  A Shimbara; P Christodoulopoulos; A Soussi-Gounni; R Olivenstein; Y Nakamura; R C Levitt; N C Nicolaides; K J Holroyd; A Tsicopoulos; J J Lafitte; B Wallaert; Q A Hamid
Journal:  J Allergy Clin Immunol       Date:  2000-01       Impact factor: 10.793

Review 3.  Heterogeneity and plasticity of T helper cells.

Authors:  Jinfang Zhu; William E Paul
Journal:  Cell Res       Date:  2009-12-15       Impact factor: 25.617

4.  Autoimmunity: increasing suspects in the CD4+ T cell lineup.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

5.  Regulation of IL-9 expression by IL-25 signaling.

Authors:  Pornpimon Angkasekwinai; Seon Hee Chang; Manoj Thapa; Hiroshi Watarai; Chen Dong
Journal:  Nat Immunol       Date:  2010-02-14       Impact factor: 25.606

6.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

Authors:  Stefanie Eyerich; Kilian Eyerich; Davide Pennino; Teresa Carbone; Francesca Nasorri; Sabatino Pallotta; Francesca Cianfarani; Teresa Odorisio; Claudia Traidl-Hoffmann; Heidrun Behrendt; Stephen R Durham; Carsten B Schmidt-Weber; Andrea Cavani
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

7.  Unlike Th1, Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation-induced cell death.

Authors:  Guangpu Shi; Madhu Ramaswamy; Barbara P Vistica; Catherine A Cox; Cuiyan Tan; Eric F Wawrousek; Richard M Siegel; Igal Gery
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

8.  Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.

Authors:  Anneli Jäger; Valérie Dardalhon; Raymond A Sobel; Estelle Bettelli; Vijay K Kuchroo
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

9.  IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.

Authors:  Jonathan S Dodd; Eda Lum; John Goulding; Roshell Muir; Jacques Van Snick; Peter J M Openshaw
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

10.  Human CD4 memory T cells can become CD4+IL-9+ T cells.

Authors:  Prabhakar Putheti; Amit Awasthi; Joyce Popoola; Wenda Gao; Terry B Strom
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more
  48 in total

Review 1.  IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.

Authors:  Junhui Li; Shuqiu Chen; Xiang Xiao; Yong Zhao; Wenjun Ding; Xian C Li
Journal:  Cytokine Growth Factor Rev       Date:  2017-07-17       Impact factor: 7.638

2.  Physical attraction of Th9 cells is skin deep.

Authors:  Valerie Dardalhon; Mary Collins; Vijay K Kuchroo
Journal:  Ann Transl Med       Date:  2015-04

Review 3.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

Review 4.  The symphony of the ninth: the development and function of Th9 cells.

Authors:  Rukhsana Jabeen; Mark H Kaplan
Journal:  Curr Opin Immunol       Date:  2012-02-22       Impact factor: 7.486

Review 5.  TH9 cells in skin disorders.

Authors:  Rachael A Clark; Christoph Schlapbach
Journal:  Semin Immunopathol       Date:  2016-11-28       Impact factor: 9.623

6.  Th2 cells as an intermediate for the differentiation of naïve T cells into Th9 cells, associated with the Smad3/Smad4 and IRF4 pathway.

Authors:  Mohamed Hamed Abdelaziz; Huixuan Wang; Jianjun Cheng; Huaxi Xu
Journal:  Exp Ther Med       Date:  2020-01-03       Impact factor: 2.447

Review 7.  Th9 cells in the pathogenesis of EAE and multiple sclerosis.

Authors:  Wassim Elyaman; Samia J Khoury
Journal:  Semin Immunopathol       Date:  2016-11-14       Impact factor: 9.623

8.  Phenotypes of Th lineages generated by the commonly used activation with anti-CD3/CD28 antibodies differ from those generated by the physiological activation with the specific antigen.

Authors:  Cuiyan Tan; Lai Wei; Barbara P Vistica; Guangpu Shi; Eric F Wawrousek; Igal Gery
Journal:  Cell Mol Immunol       Date:  2014-03-03       Impact factor: 11.530

9.  Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity.

Authors:  Christoph Schlapbach; Ahmed Gehad; Chao Yang; Rei Watanabe; Emmanuella Guenova; Jessica E Teague; Laura Campbell; Nikhil Yawalkar; Thomas S Kupper; Rachael A Clark
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

10.  Th9 cells promote antitumor immune responses in vivo.

Authors:  Yong Lu; Sungyoul Hong; Haiyan Li; Jungsun Park; Bangxing Hong; Lijuan Wang; Yuhuan Zheng; Zhiqiang Liu; Jingda Xu; Jin He; Jing Yang; Jianfei Qian; Qing Yi
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.